These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 5656771)

  • 41. Members of new FDA board tied to industry.
    Finkelstein JB
    J Natl Cancer Inst; 2008 Mar; 100(5):296-7. PubMed ID: 18314467
    [No Abstract]   [Full Text] [Related]  

  • 42. Internet eases negotiations for FDA, drug firms.
    Goedert J
    Health Data Manag; 2001 Mar; 9(3):14-5. PubMed ID: 11277031
    [No Abstract]   [Full Text] [Related]  

  • 43. Progress under the Kefauver-Harris Drug Amendments.
    Rankin WB
    Pharmakotherapia; 1964; 2(1):215-22. PubMed ID: 5875717
    [No Abstract]   [Full Text] [Related]  

  • 44. Dr. Goddard and the PMA.
    Rev Allergy; 1969 Mar; 23(3):161-3. PubMed ID: 5786222
    [No Abstract]   [Full Text] [Related]  

  • 45. Drug promotion.
    Stryer DB; Bero LA
    N Engl J Med; 1995 Apr; 332(15):1032; author reply 1033. PubMed ID: 7885416
    [No Abstract]   [Full Text] [Related]  

  • 46. Drug promotion.
    Cohen SN
    N Engl J Med; 1995 Apr; 332(15):1032; author reply 1033. PubMed ID: 7885414
    [No Abstract]   [Full Text] [Related]  

  • 47. FDA in the global village.
    Williams RD
    FDA Consum; 1992; 26(6):14-7. PubMed ID: 10119705
    [No Abstract]   [Full Text] [Related]  

  • 48. Planning for change.
    Hansen DC
    Bull Parenter Drug Assoc; 1969; 23(1):1-5. PubMed ID: 5765717
    [No Abstract]   [Full Text] [Related]  

  • 49. Commentary: can we talk? About Food and Drug Regulation and the First Amendment.
    Cohen MN
    Food Drug Law J; 2003; 58(4):741-56. PubMed ID: 15027458
    [No Abstract]   [Full Text] [Related]  

  • 50. Implications of international drug approval systems on confidentiality of business secrets in the U.S. pharmaceutical industry.
    O'Reilly JT
    Food Drug Law J; 1998; 53(1):123-32. PubMed ID: 11795328
    [No Abstract]   [Full Text] [Related]  

  • 51. [Accomplishment of the Swiss food control in 1952].
    Mitt Geb Lebensmittelunters Hyg; 1953; 44(5):407-42. PubMed ID: 13144643
    [No Abstract]   [Full Text] [Related]  

  • 52. [Problems connected with the drug provision in the United States].
    Sloot HA
    Pharm Weekbl; 1969 Jul; 104(30):914-23. PubMed ID: 5800761
    [No Abstract]   [Full Text] [Related]  

  • 53. A record of accomplishment.
    Provost GP
    Am J Hosp Pharm; 1968 Jun; 25(6):269. PubMed ID: 5656771
    [No Abstract]   [Full Text] [Related]  

  • 54. Retrospective view of the interfacial relationship of the pharmaceutical industry with the Food and Drug Administration and the United States Pharmacopeia.
    Hammer HF
    J Parenter Sci Technol; 1984; 38(4):159-63. PubMed ID: 6491859
    [No Abstract]   [Full Text] [Related]  

  • 55. Setting the record straight on PDR criticisms.
    Mehta M
    Postgrad Med; 2000 Jan; 107(1):22. PubMed ID: 10649658
    [No Abstract]   [Full Text] [Related]  

  • 56. Manufacturing misdeeds cost Abbott record-breaking payment.
    Lewis C
    FDA Consum; 2000; 34(3):38-9. PubMed ID: 11521253
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.